期刊
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
卷 81, 期 2, 页码 132-134出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2014.10.011
关键词
Carbapenem-resistant; Klebsiella pneumoniae; Aminoglycosides; Automated system; Vitek2; Etest; Broth microdilution
资金
- FP7 projects EvoTAR [HEALTH-F3-2011-2011-282004]
Performance of Vitek2, Etest, and TREK broth microdilution (BMD) panels was evaluated versus reference CLSI BMD for gentamicin susceptibility testing with 57 bloodstream isolates of KPC-producing Klebsiella pneumoniae. Compared with reference BMD, the Essential Agreement and Categorical Agreement for TREK panels, Vitek2, and Etest were 91.2%, 31.6%, and 61.4%, respectively, and 86%, 21%, and 52.6%, respectively. Four very major discrepancies occurred with Vitek2. In these 4 strains, gentamicin resistance was associated with the presence of an armA aminoglycoside resistance determinant. (C) 2015 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据